As U.S. tariffs loom, Canada should use AI to fight back
Our Chief Policy and Partnerships Officer, Richard Gold, argues that Canada has a unique opportunity to become a global leader in AI-assisted drug discovery by leveraging its strong scientific expertise and biomedical data infrastructure. To reduce reliance on the U.S., Canada must invest in large, open datasets, streamline regulations, and foster collaboration between government, academia, and […]
DMOS program funds three projects working towards treatments for rare diseases
We are proud to announce the first three recipients of funding via our Developing Medicines through Open Science program. These grantees are working towards treatments and cures for three rare diseases: a genetic neuromuscular disorder, a pediatric brain cancer, and a liver disease. Access this press release on Business Wire For more information, contact:Estrid Jakobsen […]
In Vivo features Conscience among leading nonprofits addressing biopharma market failures
In Search Of Rare Disease Treatments, Nonprofits Can Lead the Charge Read the full article in In Vivo »
Canada Can Confront US Tariffs by Liberating Innovators
Our Chief Policy and Partnerships Officer, Richard Gold, argues that if Trump goes ahead with his tariffs, Canada should use intellectual property as a weapon against the threat to national economic security – a bold step that would allow Canada to exploit its wealth of academic knowledge to produce lower-cost medicines and ramp up AI-assisted […]
Announcing a Leadership Transition at Conscience
As we approach the start of a new year, we’re announcing an important transition for Conscience – we are seeking a new CEO and a Director of Program Operations to join our leadership team, and take the organization into the future. Our inaugural CEO, Ryan Merkley, has resigned to pursue a new opportunity, and we […]
Drug development for all: How we believe Open Science can help develop treatments for those left behind
Health is core to our quality of life, yet millions worldwide lack treatments to diseases that threaten their lives or quality of life. For example, an estimated 400 million people worldwide live with a rare disease, 95% of which do not have a single treatment. Half of those individuals are children. Alzheimer’s disease and other […]
CACHE Challenge #3 identifies four ‘hits’ for potential coronavirus treatment
In our third CACHE Challenge, researchers from across the globe used computational methods to predict molecules to bind on a potential target to develop medicines against SARS-CoV-2. The four top-performing teams identified four molecules that were chemically novel and showed promise as starting points for drug development. For more information, contact:Estrid Jakobsen at [email protected] Preeti Singh […]
AstraZeneca joins CACHE Governing Board
We are pleased to announce that AstraZeneca, a global, science-led biopharmaceutical company has joined the CACHE (Critical Assessment of Computational Hit-finding Experiments) Governing Board for a two-year term, which is a critical element of Conscience’s efforts to set clear industry-leading benchmarks and improve success rates in the current drug discovery system. Bringing a wealth of […]
The 2024 Nobel Prizes in Chemistry and Physics recognize advances in fields crucial to drug discovery
The Royal Swedish Academy of Sciences on Wednesday announced the 2024 Nobel Prizes, two of which represent significant advances in scientific fields that are crucial to drug discovery and Conscience’s mission. These discoveries, which relied on high-quality, open data, exemplify the importance of both quality and openness of data for the future of AI in […]
Forbes features top-scoring CACHE 2 team and highlights importance of participation from the Global South
How Can AI Help Discover ‘New’ Drugs Against COVID-19 In Brazil? Read the full article in Forbes »
Chemical & Engineering News features Conscience and top CACHE 2 participants
Open-source competition finds potential coronavirus drugs Read the full article on Chemical & Engineering News »
Get to Know Our Partnerships Lead, Lauriane
We are excited to share a new podcast episode featuring Lauriane Gorce, Conscience’s Partnerships Lead, on Papa PhD, which aims to help students thrive beyond academia. Lauriane met David at a networking event and joined the podcast to share her journey and insights on finding a fulfilling career that balances societal impact, work, and personal […]
